AAAAAA

   
Results: 1-9 |
Results: 9
VINORELBINE PLUS CISPLATIN IN RECURRENT OR PREVIOUSLY UNTREATED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: GEBBIA V TESTA A DIGREGORIO C INGRIA F VALENZA R CANNATA G MOSCHELLA F RESTIVO G GEBBIA N
Citation: V. Gebbia et al., VINORELBINE PLUS CISPLATIN IN RECURRENT OR PREVIOUSLY UNTREATED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, American journal of clinical oncology, 18(4), 1995, pp. 293-296
PROGNOSTIC-SIGNIFICANCE OF CELL-KINETICS IN LARYNGEAL SQUAMOUS-CELL CARCINOMA - CLINICOPATHOLOGICAL ASSOCIATIONS
Authors: TOMASINO RM DANIELE E BAZAN V MORELLO V TRALONGO V NUARA R NAGAR C SALVATO M INGRIA F RESTIVO S DARDANONI G VECCHIONE A RUSSO A
Citation: Rm. Tomasino et al., PROGNOSTIC-SIGNIFICANCE OF CELL-KINETICS IN LARYNGEAL SQUAMOUS-CELL CARCINOMA - CLINICOPATHOLOGICAL ASSOCIATIONS, Cancer research, 55(24), 1995, pp. 6103-6108
FLOW CYTOMETRIC DNA ANALYSIS AND LYSOSOMAL CATHEPSIN-B AND CATHEPSIN-L IN LOCALLY ADVANCED LARYNGEAL-CANCER - RELATIONSHIP WITH CLINICOPATHOLOGICAL PARAMETERS AND PROGNOSTIC-SIGNIFICANCE
Authors: RUSSO A BAZAN V GEBBIA N PIZZOLANTI G TUMMINELLO FM DARDANONI G INGRIA F RESTIVO S TOMASINO RM LETO G
Citation: A. Russo et al., FLOW CYTOMETRIC DNA ANALYSIS AND LYSOSOMAL CATHEPSIN-B AND CATHEPSIN-L IN LOCALLY ADVANCED LARYNGEAL-CANCER - RELATIONSHIP WITH CLINICOPATHOLOGICAL PARAMETERS AND PROGNOSTIC-SIGNIFICANCE, Cancer, 76(10), 1995, pp. 1757-1764
P53 EXPRESSION IN STAGE III-IV SQUAMOUS-CELL CARCINOMA OF THE LARYNX - AN IMMUNOHISTOCHEMICAL STUDY RELATED TO CLINICOPATHOLOGICAL, FLOW-CYTOMETRIC DNA ANALYSIS AND PROGNOSIS
Authors: TOMASINO RM MORELLO V BAZAN V NAGAR C TRALONGO V DARDANONI G INGRIA F MONTELEONE G RESTIVO S NUARA R DANIELE E RUSSO A
Citation: Rm. Tomasino et al., P53 EXPRESSION IN STAGE III-IV SQUAMOUS-CELL CARCINOMA OF THE LARYNX - AN IMMUNOHISTOCHEMICAL STUDY RELATED TO CLINICOPATHOLOGICAL, FLOW-CYTOMETRIC DNA ANALYSIS AND PROGNOSIS, International journal of oncology, 5(3), 1994, pp. 495-500
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN, AND BLEOMYCIN AS 2ND-LINE CHEMOTHERAPY FOR RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/
Authors: GEBBIA V VALENZA R TESTA A BORSELLINO N CANNATA G RESTIVO S SPECIALE R INGRIA F SPADAFORA G GEBBIA N
Citation: V. Gebbia et al., METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN, AND BLEOMYCIN AS 2ND-LINE CHEMOTHERAPY FOR RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, ORL, 56(5), 1994, pp. 279-282
HEAD AND NECK-CARCINOMA WITH DISTANT METASTASES - A RETROSPECTIVE ANALYSIS OF 44 CASES TREATED WITH CISPLATIN-BASED CHEMOTHERAPEUTIC REGIMENS
Authors: GEBBIA V AGOSTARA B CALLARI A ZERILLO G RESTIVO G SPECIALE R CUPIDO G INGRIA F SPATAFORA G FAZIO L GALLINA S ZERILLO F LOBUE P TERMINI G LOMBARDO F VALENZA R TESTA A CANNATA G CIMINO A GEBBIA N
Citation: V. Gebbia et al., HEAD AND NECK-CARCINOMA WITH DISTANT METASTASES - A RETROSPECTIVE ANALYSIS OF 44 CASES TREATED WITH CISPLATIN-BASED CHEMOTHERAPEUTIC REGIMENS, Anticancer research, 13(4), 1993, pp. 1129-1131
A PHASE-II STUDY OF LEVOFOLINIC ACID AND 5-FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: GEBBIA V TESTA A VALENZA R ZERILLO G RESTIVO S CUPIDO G INGRIA F BARBACCIA C SPADAFORA G CANNATA G GEBBIA N
Citation: V. Gebbia et al., A PHASE-II STUDY OF LEVOFOLINIC ACID AND 5-FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Oncology, 50(6), 1993, pp. 490-494
CHEMOTHERAPEUTIC TREATMENT OF RECURRENT AND OR METASTATIC NASOPHARYNGEAL CARCINOMA - A RETROSPECTIVE ANALYSIS OF 40 CASES
Authors: GEBBIA V ZERILLO G RESTIVO G SPECIALE R CUPIDO G LOBUE P INGRIA F GALLINA S SPATAFORA G TESTA A CANNATA G CIMINO A GEBBIA N
Citation: V. Gebbia et al., CHEMOTHERAPEUTIC TREATMENT OF RECURRENT AND OR METASTATIC NASOPHARYNGEAL CARCINOMA - A RETROSPECTIVE ANALYSIS OF 40 CASES, British Journal of Cancer, 68(1), 1993, pp. 191-194
WEEKLY 5-FLUOROURACIL AND FOLINIC ACID PLUS ESCALATING DOSES OF CISPLATIN WITH GLUTATHIONE PROTECTION IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
Authors: GEBBIA V VALENZA R TESTA A ZERILLO G RESTIVO S CUPIDO G INGRIA F SPADAFORA G BARBACCIA C CANNATA G CIPOLLA C GEBBIA N
Citation: V. Gebbia et al., WEEKLY 5-FLUOROURACIL AND FOLINIC ACID PLUS ESCALATING DOSES OF CISPLATIN WITH GLUTATHIONE PROTECTION IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER, Medical oncology and tumor pharmacotherapy, 9(4), 1992, pp. 165-168
Risultati: 1-9 |